|Articles|May 20, 2021
Process Purification Development of Retrovirus-like Particle
Author(s)Bio-Rad Laboratories
Read a case study about resin screening, process development, and scale-up purification of a retrovirus-like particle which was scalable, fast, and low-cost during the clinical-grade manufacture of retrovirus vectors.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Implementing Automation and Flexible Design for Allogeneic Manufacturing
2
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
3
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
4
Biocapacitance as a PAT Tool: Real-Time Biomass Monitoring for Upstream Bioprocessing
5
